We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The literature regarding breastfeeding and effects of anti-seizure medication (ASM) exposure via breastmilk has evolved over the past two decades, with mounting evidence that supports breastfeeding for women with epilepsy (WWE) taking ASMs. In this chapter, we provide an overview of the current evidence that supports breastfeeding in infants of mothers taking ASM; safety profile of each ASM and reported adverse effects for various ASMs. Lastly, we review rates and patterns, as well as potential barriers to breastfeeding in WWE and potential intervention to improve breastfeeding practices in WWE.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.